We assign Teva a Morningstar Uncertainty Rating of High, which largely reflects our quantitative analysis of the firm, based on the return ranges used by our star rating system, as well as our ...

The pharmaceutical industry is on the verge of a significant transformation due to the emergence of artificial intelligence ...

Sage Therapeutics has rejected the unsolicited acquisition offer it received earlier this month from longtime partner Biogen ...

With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

Renewed interest in psychedelics as treatments for mental disorders has recently emerged, but substantial challenges remain in obtaining evidence from available data to inform clinical decision ...

Pharmaceutical firms that specialize in utilizing AI to speed up the drug discovery process are soaring today.

"Delphine's breadth of pharmaceutical development experience ... the risks inherent in the drug development process, the risks regarding the accuracy of our estimates of expenses and timing of ...

"Delphine's breadth of pharmaceutical development experience ... the risks inherent in the drug development process, the ...

"And we're not used to having somebody without a career at stake in the room at a senior level," said Hudson.

In this interview, we explore the key changes shaping the pharmaceutical industry, maintaining compliance across global ...

In the last few months, some unscrupulous elements have intensified their illegal operations across the country, freely circulating fake and substandard drugs as well as unwholesome food and drinks.